HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration’s (DEA) proposed aggregate production quotas for Schedule I and II controlled substances.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers.
Related Posts
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation
Washington, DC (November 28, 2018) – Healthcare Supply Chain Association (HSCA)...
HSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
Washington, DC (August 21, 2018) – The Healthcare Supply Chain Association...
Comments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
On behalf of the Healthcare Supply Chain Association (HSCA), thank you for the...